The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side EffectsChristoph Wießner, M. Staufenbiel|Journal of Neuroscience|2011Cited by 190